LAS VEGAS, Sept. 7 /PRNewswire-FirstCall/ -- DTI Medical Corporation (Pink Sheets: DTIM) announced and publicly-noticed its shareholders that it will affect a reverse split of its common stock and authorize its Board of Directors to affect a name change. Questions regarding the reverse split will be handled through the Company's transfer agent, Standard Registrar & Transfer Company, Inc., Draper, Utah. Notice of the intended and pending corporate action is as follows:
NOTICE OF SHAREHOLDER CONSENT
IN LIEU OF A SPECIAL MEETING
OF THE SHAREHOLDERS OF
DTI MEDICAL CORPORATION
The Board of Directors of DTI Medical Corporation, a Nevada corporation ("the Company"), hereby gives notice that pursuant to Nevada Corporate Statutes, a majority of the shareholders of record of the Company, as of September 7, 2007, will consent to the following action effective September 17, 2007.
1. Affect a reverse split of the Company's outstanding common shares for
up to a 1 for 300 basis.
2. Authorized the Board of Directors to affect a name change to a name to
be selected by the Board.
Proxies of the shareholders are not being solicited by the Board of Directors.
Dated this 7th day of September, 2007. By Order Of: The Board of Directors
Statements contained herein that are not historical facts are
forward-looking statements within the meaning of the Securities Act of
1933, as amended. Those statements include statements regarding the intent,
belief or current expectations of the company and its management. Such
statements reflect management's current views, are based on certain
assumptions and involve risks and uncertainties. Actual results, events, or
performance may differ materially from the above forward-looking statements
due to a number of important factors, and will be depende
|SOURCE DTI Medical Corporation|
Copyright©2007 PR Newswire.
All rights reserved